Silo Pharma (SILO) news
Recent news
Silo Pharma: selling shareholders offer on resale basis 1.9 mln shares of Silo Pharma common stock - SEC filing
Silo Pharma has announced that selling shareholders are offering 1.9 million shares of its common stock on a resale basis, as disclosed in a recent SEC filing [1]. The offering is part of a registered resale of previously issued shares and does not involve the company issuing new stock or receiving…
AInvest Wire · Jul 24, 2026Silo Pharma announces up to $11.7 million private placement priced at-the-market under Nasdaq rules
AInvest Wire · Jul 10, 2026Silo Pharma - expects $4 mln gross proceeds from offering before fees
AInvest Wire · Jul 10, 2026Silo Pharma - data to support planned FDA Type C meeting request for IND strategy and Phase 1 design
AInvest Wire · Jun 29, 2026Silo Pharma regains compliance with Nasdaq minimum bid price requirement
Silo Pharma, Inc. (NASDAQ: SILO) has been granted an extension by Nasdaq to regain compliance with the minimum bid price requirement for its common stock. The company now has until June 22, 2026, to meet the $1.00 per share threshold mandated by Nasdaq Listing Rule 5550(a)(2) . As of the latest…
AInvest Wire · Jun 18, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.